Navigation Links
Allergy Technologies LLC Provides Over $100,000 in a Research Grant to The Ohio State University for the Study of Bed Bugs
Date:8/9/2011

AMBLER, Pa., Aug. 9, 2011 /PRNewswire/ -- Allergy Technologies LLC, manufacturer of ActiveGuard™ mattress liners, is sponsoring a new bed bug research program at The Ohio State University through an initial $100,000+ grant provided by the Company.

This new endeavor will examine the importance and effects of specific products, protocols and strategies relating to innovative bed bug treatment applications. The dramatic rise in bed bug infestations throughout the country in the last ten years has created a need for more research to improve and expand pest management practices. Based on mutual agreement between The Ohio State University and Allergy Technologies, this grant provides a 2nd year renewal opportunity for an additional $100,000+ in funding.

According to Susan Jones, Ph.D., entomologist at The Ohio State University, the grant provided by Allergy Technologies will allow Jones and her urban entomology team to pursue sorely needed bed bug-related research leading to implementation of new and improved strategies for controlling bed bugs.

"This grant will enable us to embark upon important and in-depth research on product efficacy, treatment protocols, and application methods as we work to control bed bugs," said Dr. Jones. "With the current emergence of bed bug infestations, Allergy Technologies' sponsorship will allow us to pursue fundamental lab and applied field research.  This programmatic research is geared toward investigating novel strategies in bed bug treatment leading to improved and effective solutions."

"We are proud to be able to support this university research.  This grant evidences Allergy Technologies' continued commitment to developing bona fide research-based treatments aimed directly toward the bed bug scourge that is blanketing our country," stated Gus Carey, Managing Director of Allergy Technologies.

ActiveGuard by Allergy Technologies LLC, is a thin and breathable liner easily installed onto mattresses and box springs, which kill bed bugs and dust mites continuously for up to two years.

According to Joseph Latino, Director of Technical Services for Allergy Technologies, "We are highly optimistic that the findings from these studies will benefit the entire pest management industry toward reaching a common goal - establishing rigorous scientifically supported treatment options for controlling bed bugs."

Distinct from encasements and originally developed as a natural extension of the globally used mosquito nets by a team of research entomologists for use against dust mites, ActiveGuard has been extensively lab and field tested for use in both active and preventative bed bug control strategies.

About Allergy Technologies

Allergy Technologies is a subsidiary of A. Carey Co. LLC, which focuses on using philanthropy as a core business strategy for its businesses. Through its Philanprofit strategy, a portion of all ActiveGuard proceeds go to help fund inner-city homeless and women's shelters and asthma clinics.

For more information, call (866) 978-6288 or visit www.allergytechnologies.com.

Media Contact:
Ed DeMask
DeMask Marketing
630-768-1404, cell
630-389-0572, office
ed@demaskmarketing.com


'/>"/>
SOURCE Allergy Technologies LLC
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Food Allergies Common among Children and Linked to Environmental Allergies and Asthma Later in Life, Suggests Largest-Ever National Allergy Study
2. Cobalis Corp. Launches National Television Commercials for PreHistin® Allergy Defense Formula
3. Dey Pharma Commemorates 14th Annual Food Allergy Awareness Week
4. Allergy Relief Moms Can Rely On
5. Cinryze® (C1 Esterase Inhibitor [Human]) Data Presented at 2011 American Academy of Allergy Asthma & Immunology (AAAAI) Annual Meeting
6. National Nasal Allergy Survey Reveals Unmet Needs Still Exist Among Patients Living With Allergic Rhinitis
7. PreHistin ® Allergy Defense Formula Wins 2011 Best New Product Award at ECRM Allergy Show
8. Sams Club® Offers Free Allergy Health Screenings
9. Cobalis Corp. Receives $415,000 First Purchase Order from Major Retail Pharmacy for PreHistin® Allergy Defense Formula
10. Good Clostridia in the Gut Protect from Allergy and Autoimmunity
11. Cinryze® (C1 Esterase Inhibitor [Human]) Data Presented at 2010 International Scientific Conference of the World Allergy Organization (WAO)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... 24, 2016  Arkis BioSciences, a leading innovator ... more durable cerebrospinal fluid treatments, today announced it ... funding is led by Innova Memphis, followed by ... private investors.  Arkis, new financing will accelerate the ... market release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... "Dialysis Devices Global Market - Forecast to 2022" report ... is the treatment method for the patients with kidney failure, ... and excess fluid from the patient,s blood and thus the ... sodium, potassium and chloride in balance. Increasing ...
(Date:6/23/2016)... 23, 2016 Research and Markets ... Market by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic ... Coating, Parenteral) - Global Forecast to 2021" report ... The global pharmaceutical excipients market is projected to ... of 6.1% in the forecast period 2016 to 2021. ...
Breaking Medicine Technology:
(Date:6/26/2016)... ... June 27, 2016 , ... Quality metrics are proliferating in cancer care, and ... in the eye of the beholder, according to experts who offered insights and commentary ... of Managed Care. For the full issue, click here . , For the ...
(Date:6/26/2016)... ... June 26, 2016 , ... Many women are ... with endometriosis. These women need a treatment plan to not only alleviate symptoms ... can help for preservation of fertility and ultimately achieving a pregnancy. The specialists ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency Room , the largest ... as the Medical Director of its new Mesquite-Samuell Farm facility. , “We are ... Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director of First Choice Emergency ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published ... unfamiliar with. The article goes on to state that individuals are now more comfortable ... less common operations such as calf and cheek reduction. The Los Angeles area medical ...
(Date:6/24/2016)... ... June 24, 2016 , ... Global law firm Greenberg Traurig, P.A. announced that ... chosen by their peers for this recognition are considered among the top 2 percent ... special honors as members of this year’s Legal Elite Hall of Fame: Miami ...
Breaking Medicine News(10 mins):